Navigation Links
NICE supports application of advanced biological therapies as treatment option for acute psoriasis

these therapies available as quickly as possible."

Patients who would like to find out more about biological therapy are advised to talk to their dermatologist.

In the European Union, Enbrel? is approved for the treatment of adults with moderate to severe plaque psoriasis who failed to respond to, or who have a contraindication to, or are intolerant to other systemic therapy including cyclosporine, methotrexate or PUVA (Psoralen (a light-sensitizing medication) combined with exposure to ultraviolet light A (UVA). Enbrel is also approved for the treatment of active and progressive psoriatic arthritis in adults when the response to previous disease-modifying antirheumatic drug therapy has been inadequate.

Physicians in Europe have become familiar with the benefits and long-term tolerability profile of ENBREL since it became commercially available over six years ago. More than 400,000 patients have been treated worldwide across indications. Enbrel is a recombinant human tumour necrosis factor (TNF) receptor fusion protein that inhibits the activity of TNF. TNF is a cytokine that is released from T lymphocytes; it mediates inflammation and modulates the cellular immune response. Enbrel is also indicated for treatment of the following:

Severe, active and progressive rheumatoid arthritis in adults not previously treated with methotrexate. Active Juvenile Idiopathic Arthritis in children aged 4 to 17 years who have had an inadequate response to, or who have proved intolerant of, methotrexate. Enbrel has not been studied in children aged less than 4 years. Severe active ankylosing spondylitis in adults who have had an inadequate response to conventional therapy.

Since the product was first introduced, serious infections, some involving death, have been reported in patients using ENBREL. Patients should tell their doctor if they currently have an infection or are prone to getting infections. Patients should not sta
'"/>




Page: 1 2 3 4

Related medicine news :

1. Vitamin E supports Female Hearts
2. Injection supports Heart Devices
3. Study supports vegetable diet
4. Study supports century-old cancer theory
5. Novartis files application with FDA for Zometa
6. Morepan to file new drug applications with the USFDA
7. Mini motor for micromedical applications
8. Perfusion bioreactor could enhance stem cell research and application in the future
9. Innovative device aids in advanced heart failure
10. Light therapy devotes new hope in advanced lung cancer
11. Race an important links to the risk of advanced colorectal cancer
Post Your Comments:
(Date:8/1/2014)... DC (PRWEB) August 01, 2014 ... offer health plans and employers effective options to ... narrow networks argue that they can enhance formulary ... administrative fees. Consultants report that nearly all PBMs ... to requests for proposals. The Aug. 12 ...
(Date:8/1/2014)... 2014 Millions of women suffer with ... and in some cases the arms, causing an abnormal ... 17 million women in the U.S. alone are affected. ... the pain, embarrassment and discomfort caused by lipedema, it’s ... are unaware that this is a disease,” says Dr. David ...
(Date:8/1/2014)... August 01, 2014 Get the report ... with PitchBook presents the 3Q 2014 Private Equity Breakdown ... equity investment, exits and fundraising activity in the second ... help plan for private equity endeavors for the remainder ... to download it now. , About Merrill DataSite , ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 The ... important developments about chemical listings, appellate decisions, litigation ... that may affect compliance with California's Proposition 65. ... to the law, regulations, history and trends impacting ... the fourth installment of the series which adds ...
(Date:7/31/2014)... recently used birth control pills containing high-dose estrogen and ... breast cancer, whereas women using some other formulations did ... , a journal of the American Association for Cancer ... oral contraceptives [birth control pills] in the past year ... to never or former oral contraceptive use, and that ...
Breaking Medicine News(10 mins):Health News:Atlantic Information Services Webinar to Offer Health Plan, Employer Strategies for Implementing Narrow Pharma Networks 2Health News:Lipedema Centers Works With Insurers To Gain Coverage For Lipedema Treatment 2Health News:Register to Download Merrill DataSite's Report: PitchBook 3Q 2014 Private Equity Breakdown Report 2Health News:Save 25% on the Proposition 65 Handbook - 2013 Edition Through August 31 2Health News:Recent use of some birth control pills may increase breast cancer risk 2
... is a sad day for the American labor movement and ... the bottom up, rather than the top down.SEIU,s press release ... It also is predictable that Hearing Officer Ray Marshall, former ... Stern to conduct the hearing would do the job he ...
... 22 Novo Nordisk, a global healthcare company focusing on ... "100 Best Companies to Work For" awards issue. This is ... award -- one of the most influential business scorecards in ... For" are historically good performers in the marketplace for not ...
... 22 Missouri Congressman Roy Blunt today reflected on the ... v. Wade by speaking with the Missouri-Illinois Right to Life ... in sending a letter to President Barack Obama urging him ... "The last few years are the first time since I,ve ...
... preventable blindnessOAK BROOK, Ill., Jan. 22 The ... http://www.newscom.com/cgi-bin/prnh/20081014/DC38855LOGO ) Who: Former President ... Lions Clubs International President Albert Brandel; ... Dedication of the "Gift of Sight" statue, ...
... 22 Griffin Hospital has been honored with a 10th year ... Griffin ranked 62 on the 2009 list released today. Griffin is ... ten years.Griffin was first invited to apply for selection to the ... since. FORTUNE has issued the list of "100 Best Companies to ...
... announced today that,the physicians of Midwest Pulmonary and ... , The physicians are Susan ... Plumb, M.D. All are board-certified in pulmonology,and critical care ... the treatment of sleep disorders. , ...
Cached Medicine News:Health News:Statement by UHW on SEIU's Claims Regarding SEIU-Trusteeship Hearing Process Chaired by Ray Marshall 2Health News:Novo Nordisk Makes its Debut in FORTUNE's '100 Best Companies to Work For' 2Health News:Novo Nordisk Makes its Debut in FORTUNE's '100 Best Companies to Work For' 3Health News:Blunt Marks Anniversary of Roe v. Wade, Signs Letter in Defense of Pro-Life Legislation 2Health News:Blunt Marks Anniversary of Roe v. Wade, Signs Letter in Defense of Pro-Life Legislation 3Health News:Former President Jimmy Carter Dedicates 'Gift of Sight' Statue at Lions Club International Headquarters in Recognition of Lions' Blindness Prevention Efforts 2Health News:Griffin Honored with Tenth Year on FORTUNE Best Companies to Work for List 2Health News:Midwest Pulmonary and Critical Care Associates Will Join Aurora Medical Group 2
(Date:7/31/2014)... MONROVIA, Calif., July 31, 2014 Xencor ... biopharmaceutical company developing engineered monoclonal antibodies for the ... and cancer, today reported financial results for the ... review of recent business highlights. "In ... the American Thoracic Society 2014 International Conference (ATS) ...
(Date:7/31/2014)... Nektar Therapeutics (Nasdaq: NKTR ) today reported its ... Cash and investments in marketable securities at ... million at March 31, 2014."The second half of 2014 will ... to significant milestones for a number of our late-stage clinical ... of Nektar. "The first of these is the potential US ...
(Date:7/31/2014)... -- UBM Medica US announces that Cancer Network ... exclusive slide shows dealing with communication in the oncology ... Cancer Network, the online home ... and podcasts about the latest clinical findings. Among the ... , End-of-life care is challenging for even the most ...
Breaking Medicine Technology:Xencor Reports Second Quarter 2014 Financial Results 2Xencor Reports Second Quarter 2014 Financial Results 3Xencor Reports Second Quarter 2014 Financial Results 4Xencor Reports Second Quarter 2014 Financial Results 5Xencor Reports Second Quarter 2014 Financial Results 6Xencor Reports Second Quarter 2014 Financial Results 7Xencor Reports Second Quarter 2014 Financial Results 8Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 2Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 3Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 4Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 5Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 6Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 7Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 8Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 9Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 10Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 11Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 12Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 13Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 14Cancer Network Highlights Methods Oncologists Can Use to Improve Communication 2Cancer Network Highlights Methods Oncologists Can Use to Improve Communication 3
A sturdy, robust stool. Gas operated height adjustment for convenience....
Lacrimal Cannulas, 19 g. shaft tapering to 23 g. cannula, straight. Overall length 37.5 mm. 5/box....
Viscoelastic Cannula, 27 g. Angled. 7 mm angled tip cannula with unique hub that facilitates flow of viscoelastic material. Overall length 23 mm. 5/box....
Anterior Chamber Needle, 27 g. Angled. 5 mm angled tip. Overall length 20 mm. 5/box....
Medicine Products: